Social prescribing: friend or foe for pharma?
As the number of patients being diagnosed with mental health conditions, diabetes, and other chronic conditions increases, more primary care …
Hepion shelves Phase II NASH trial amid shallow cash resources
Hepion Pharmaceuticals has called it quits on a Phase IIb trial investigating the biotech’s lead drug candidate for the treatment …
Investors advocate for early biotech partnerships for later deal success
Following 2023’s stiff economic environment, companies must prioritise partnerships more than ever in their growth strategies, said Richard Girling, a …
Smaller regulators grasp innovation through international collaboration
Smaller regulatory agencies could introduce more therapies into their national markets through faster regulatory processes, said Dr. Ulf Grawunder, managing …
Targeting mouth cancer with light-activated drugs
With two in five patients with oral cancer dying within five years and 95% of patients requiring life-altering surgery, finding …
EC approves BeiGene’s tislelizumab for three NSCLC indications
BeiGene has announced that its anti-programmed cell death protein 1 (PD-1) monoclonal antibody, tislelizumab, has gained European Commission (EC) approval …
Moderna gets grant for vaccine composition for varicella zoster virus
Moderna has been granted a patent for a nucleic acid vaccine that includes RNA polynucleotides encoding varicella zoster virus antigens. …
Bristol-Myers Squibb gets grant for humanized antibodies binding CD40 for treatment of CD40-related diseases
Bristol-Myers Squibb has patented a pharmaceutical composition containing antibodies that bind to human CD40 without activating it. The antibodies may …
Bayer gets grant for herbicide composition with glyphosate, amidoalkylamine surfactant, and co-surfactant
Bayer has been granted a patent for an herbicidal composition containing glyphosate, amidoalkylamine surfactants, and co-surfactants. The concentrate solution includes …
AstraZeneca gets grant for inhibitors of complement factor d for treating disorders
AstraZeneca has been granted a patent for compounds targeting complement Factor D to regulate the complement cascade and reduce excessive …
Insmed gets grant for treatment of gram-positive pulmonary bacterial infections
Insmed has been granted a patent for lipo-glycopeptide cleavable derivatives to treat bacterial infections, particularly in the lungs. The compounds …
Omeros gets grant for treating diffuse alveolar hemorrhage with MASP-2 inhibitory antibody
Omeros has been granted a patent for a method to treat graft-versus-host disease and other conditions post hematopoietic stem cell …
Sangamo Therapeutics gets grant for non-naturally occurring nucleases with alternative configurations
Sangamo Therapeutics has patented compositions for creating non-naturally occurring nucleases by linking DNA binding domains and cleavage domains. The patent …
Takara gets grant for selective separation of target nucleic acids from a composition
Takara has been granted a patent for methods of depleting target nucleic acids from a collection. The method involves using …
MiMedx Group gets grant for amniotic fluid compositions kit with administration device
MiMedx Group has been granted a patent for compositions containing amniotic fluid, a carrier, and placental tissue components. The patent …